Related Experiment Video
Updated: May 28, 2026
08:44
Dual Test Gas Pulmonary Diffusing Capacity Measurement During Exercise in Humans Using the Single-Breath Method
Published on: February 2, 2024
Clinical, Functional, and Comorbid Characteristics of COPD Patients with Impaired Diffusing Capacity: A
1The Fourth Clinical College, Chongqing Medical University, Chongqing 400016, China.
Journal of Clinical Medicine
|May 27, 2026
Summary
Reduced diffusing capacity of the lung for carbon monoxide (DLCO) in COPD patients is linked to male sex, older age, malnutrition, and worse lung function. DLCO impairment highlights distinct clinical phenotypes and aids in characterizing COPD severity.
Area of Science:
- Pulmonary Medicine
- Respiratory Physiology
- Clinical Diagnostics
Background:
- The diffusing capacity of the lung for carbon monoxide (DLCO) is crucial for assessing alveolar-capillary gas exchange.
- The clinical significance of DLCO impairment in chronic obstructive pulmonary disease (COPD) requires further definition.
Purpose of the Study:
- To characterize COPD patients in a Chinese cohort based on DLCO impairment.
- To evaluate DLCO as a marker for disease severity and clinical phenotyping in COPD.
Main Methods:
- Retrospective cross-sectional study of 650 COPD patients stratified by predicted DLCO%.
- Collected demographic, clinical, functional, and comorbidity data.
- Utilized ANOVA, Kruskal-Wallis, chi-square, Fisher's exact tests, and Spearman correlation.
Main Results:
- Progressive DLCO impairment correlated with male sex, older age, lower BMI, higher smoking rates, and increased tuberculosis prevalence.
- Worsened spirometry, elevated inflammatory markers (NLR, SII), and decreased hemoglobin/albumin were observed.
- Severe DLCO impairment was linked to respiratory failure and a trend toward higher pulmonary hypertension risk.
Conclusions:
- DLCO impairment in COPD is associated with specific clinical phenotypes, including malnutrition, systemic inflammation, and cardiorespiratory dysfunction.
- DLCO serves as a valuable complementary marker for characterizing COPD severity.
- Further longitudinal studies are recommended to establish the prognostic value of DLCO.
Keywords:
chronic obstructive pulmonary disease (COPD)clinical characteristicsdiffusing capacity of the lung for carbon monoxide (DLCO)prognosisrisk stratificationMore Related Videos
Related Concept Videos
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...